Terms: = Kidney tumors AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Staging
4 results:
1. Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.
Rossi S; Toschi L; Castello A; Grizzi F; Mansi L; Lopci E
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2310-2325. PubMed ID: 28815334
[TBL] [Abstract] [Full Text] [Related]
2. Biomarkers in renal cell carcinoma.
McGuire BB; Fitzpatrick JM
Curr Opin Urol; 2009 Sep; 19(5):441-6. PubMed ID: 19584732
[TBL] [Abstract] [Full Text] [Related]
3. Risk stratification and prognostication of renal cell carcinoma.
Ficarra V; Galfano A; Novara G; Iafrate M; Brunelli M; Secco S; Cavalleri S; Martignoni G; Artibani W
World J Urol; 2008 Apr; 26(2):115-25. PubMed ID: 18392834
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic biomarkers in renal cell carcinoma.
Jiang Z
Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
[TBL] [Abstract] [Full Text] [Related]
